Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 CAD | -5.00% | 0.00% | -47.22% |
04-25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
03-22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
Business Summary
Number of employees: 100
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Hospital Specialty Products
100.0
%
| 28 | 100.0 % | 54 | 100.0 % | +94.31% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 28 | 100.0 % | 54 | 100.0 % | +94.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Saviuk
FOU | Founder | 65 | 03-03-26 |
Pascal Tougas
DFI | Director of Finance/CFO | - | 11-19 |
Nelly Komari
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 19-05-31 |
Corporate Officer/Principal | - | 23-07-31 | |
Kyle Steiger
PRN | Corporate Officer/Principal | - | 22-08-29 |
David Newell
SAM | Sales & Marketing | - | 11-10-31 |
General Counsel | 56 | 16-01-24 | |
Guy-Paul Allard
LAW | General Counsel | 56 | 16-03-31 |
Helen Saviuk
PRN | Corporate Officer/Principal | 71 | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard MacKay
CHM | Chairman | 89 | 18-07-24 |
Steven Saviuk
FOU | Founder | 65 | 03-03-26 |
Marc Léger
BRD | Director/Board Member | 65 | 22-04-26 |
Richard Lajoie
BRD | Director/Board Member | - | 11-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 98,675,427 | 52,181,062 ( 52.88 %) | 0 | 52.88 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.22% | 7.25M | |
+33.10% | 709B | |
+30.77% | 595B | |
-1.81% | 367B | |
+20.22% | 334B | |
+5.96% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.29% | 171B |
- Stock Market
- Equities
- VPH Stock
- Company Valeo Pharma Inc.